Escalon Medical Corp
OTC:ESMC
Balance Sheet
Balance Sheet Decomposition
Escalon Medical Corp
Escalon Medical Corp
Balance Sheet
Escalon Medical Corp
| Jun-2002 | Jun-2003 | Jun-2004 | Jun-2005 | Jun-2006 | Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
13
|
5
|
3
|
9
|
4
|
2
|
3
|
2
|
1
|
3
|
2
|
2
|
1
|
1
|
1
|
0
|
1
|
2
|
1
|
1
|
0
|
1
|
|
| Cash Equivalents |
0
|
0
|
13
|
5
|
3
|
9
|
4
|
2
|
3
|
2
|
1
|
3
|
2
|
2
|
1
|
1
|
1
|
0
|
1
|
2
|
1
|
1
|
0
|
1
|
|
| Short-Term Investments |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
2
|
2
|
3
|
5
|
4
|
5
|
4
|
5
|
4
|
5
|
3
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| Accounts Receivables |
2
|
2
|
2
|
5
|
4
|
5
|
4
|
5
|
4
|
5
|
3
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
2
|
2
|
2
|
6
|
7
|
8
|
9
|
10
|
7
|
6
|
4
|
2
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
2
|
2
|
2
|
2
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Current Assets |
4
|
5
|
18
|
18
|
15
|
22
|
17
|
18
|
17
|
13
|
8
|
7
|
7
|
6
|
5
|
4
|
5
|
4
|
4
|
5
|
4
|
5
|
4
|
5
|
|
| PP&E Net |
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| PP&E Gross |
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
1
|
2
|
1
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Intangible Assets |
1
|
1
|
1
|
1
|
1
|
1
|
3
|
4
|
3
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
11
|
11
|
11
|
20
|
21
|
21
|
12
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
11
|
11
|
11
|
20
|
21
|
21
|
12
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
17
N/A
|
17
0%
|
29
+74%
|
40
+36%
|
39
-4%
|
45
+17%
|
32
-29%
|
25
-21%
|
22
-12%
|
17
-22%
|
10
-43%
|
7
-25%
|
8
+5%
|
7
-15%
|
6
-16%
|
5
-10%
|
5
+9%
|
5
-6%
|
6
+12%
|
6
-1%
|
5
-9%
|
5
+3%
|
5
-10%
|
5
+5%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
1
|
0
|
1
|
1
|
2
|
2
|
3
|
3
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
1
|
1
|
1
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
2
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
2
|
2
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
|
| Total Current Liabilities |
5
|
4
|
4
|
4
|
4
|
5
|
6
|
7
|
6
|
6
|
8
|
3
|
3
|
3
|
3
|
3
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Long-Term Debt |
5
|
4
|
2
|
0
|
0
|
0
|
0
|
5
|
3
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Total Liabilities |
10
N/A
|
8
-18%
|
6
-25%
|
6
-8%
|
6
+0%
|
6
+1%
|
7
+31%
|
13
+71%
|
10
-21%
|
11
+11%
|
9
-18%
|
3
-62%
|
4
+22%
|
4
-15%
|
4
+2%
|
4
+5%
|
3
-21%
|
3
-2%
|
4
+42%
|
4
+0%
|
4
-13%
|
3
-9%
|
3
-13%
|
3
+4%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
39
|
37
|
33
|
31
|
33
|
27
|
42
|
55
|
55
|
61
|
68
|
66
|
66
|
67
|
68
|
69
|
68
|
68
|
69
|
69
|
69
|
68
|
69
|
68
|
|
| Additional Paid In Capital |
46
|
46
|
56
|
64
|
66
|
66
|
66
|
67
|
68
|
68
|
69
|
69
|
70
|
70
|
70
|
70
|
70
|
70
|
70
|
70
|
70
|
70
|
70
|
70
|
|
| Other Equity |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
7
N/A
|
9
+24%
|
23
+162%
|
35
+47%
|
33
-4%
|
39
+19%
|
25
-38%
|
12
-49%
|
12
-3%
|
6
-49%
|
1
-90%
|
4
+498%
|
3
-10%
|
3
-14%
|
2
-36%
|
1
-38%
|
2
+104%
|
2
-10%
|
2
-30%
|
1
-3%
|
1
+1%
|
2
+31%
|
2
-6%
|
2
+6%
|
|
| Total Liabilities & Equity |
17
N/A
|
17
0%
|
29
+74%
|
40
+36%
|
39
-3%
|
45
+16%
|
32
-29%
|
25
-21%
|
22
-12%
|
17
-22%
|
10
-43%
|
7
-25%
|
8
+5%
|
7
-15%
|
6
-16%
|
5
-10%
|
5
+9%
|
5
-6%
|
6
+12%
|
6
-1%
|
5
-9%
|
5
+3%
|
5
-10%
|
5
+5%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
3
|
3
|
5
|
6
|
6
|
6
|
6
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
8
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|